While many people living with hepatitis C never have serious symptoms, some develop fibrosis or cirrhosis (scarring of the liver). All people living with HIV should be tested for hepatitis C, with a blood test.

Hepatitis C symptoms and diagnosis: latest news

Hepatitis C symptoms and diagnosis resources

  • Hepatitis C

    Hepatitis C can cause the same types of symptoms and long-term liver damage as hepatitis B, although the two viruses are not closely related. Recent estimates find...

    From: Booklets

    Information level Level 2
  • Hepatitis C and HIV

    Hepatitis C is a blood-borne infection that is transmitted in some of the same ways as HIV.Over time untreated hepatitis C...

    From: Factsheets

    Information level Level 2
  • Hepatitis C

    Hepatitis C is a serious infection caused by a virus.It damages the liver, which performs essential functions in the body.Some people have hepatitis C for...

    From: The basics

    Information level Level 1

Hepatitis C symptoms and diagnosis features

Hepatitis C symptoms and diagnosis in your own words

Hepatitis C symptoms and diagnosis news from aidsmap

More news

Hepatitis C symptoms and diagnosis news selected from other sources

  • Egypt to launch largest anti-Hepatitis C campaign ever in October

    Egypt will launch the "largest medical campaign in the world" next October to detect and treat Hepatitis C virus for 50 million citizens upon President Abdel Fatah al-Sisi’s orders, according to Wednesday statement by Presidential Spokesperson Bassam Rady.

    13 September 2018 | Egypt Today
  • Hologic's Global Access Initiative Increases Availability of Diagnostic Testing in Resource-Limited Countries

    Hologic, Inc. announced today the launch of the new Hologic Global Access Initiative, in partnership with the Clinton Health Access Initiative (CHAI) and MedAccess (backed by the U.K. government), to increase affordable access to molecular testing for HIV, hepatitis B and C (HBV and HCV) and human papillomavirus (HPV) in nearly 50 nations around the world. These countries, primarily across Africa and Southeast Asia, make up 90 percent of the HIV disease burden globally.

    25 July 2018 | Hologic press release
  • FIND and DNDi support Malaysian MOH to simplify and decentralize HCV screening & treatment

    FIND and the DNDi will partner to generate evidence that will support policy change and scale up of hepatitis C diagnosis and treatment. This work, announced at the AIDS 2018 conference in Amsterdam and ahead of World Hepatitis Day 2018, is being conducted in collaboration with the Ministry of Health in Malaysia with a view to overcoming barriers to diagnosis and treatment.

    23 July 2018 | Eurekalert Inf Dis
  • Cost-effective universal screening for hepatitis C in France

    The modeling results show that universal screening is associated with better life expectancy adjusted for quality of life than other strategies. Universal screening is cost-effective if the patients tested for HCV infection are treated rapidly after diagnosis.

    02 July 2018 | EurekAlert (press release)
  • EATG launches a report on access to HCV-related services in the penitentiary system in Europe

    Drawing on research on the state of access to services related to Hepatitis C in prison settings in Europe and Central Asia, which has highlighted major shortcomings across the countries as well as some promising practices in few countries, the European AIDS Treatment Group calls on national and prison authorities to scale up access to voluntary and confidential testing and counselling for people in detention.

    23 May 2018 | EATG
  • Acute HCV spontaneous clearance rates low among HIV coinfected

    Most patients with HIV who become infected with hepatitis C will not clear the infection spontaneously and face a chronic course, according to a study presented at the Conference on Retroviruses and Opportunistic Infections, also known as CROI. The researchers advocate for amended direct-acting drug labels and guidelines to allow usage of DAA therapy during the acute phase of HCV in high-risk individuals.

    13 March 2018 | Healio
  • Deaths from liver cancer nearly double since the 1990s, new figures reveal

    Over the last two decades, deaths caused by liver cancer have increased by 80 percent, making it one of the fastest-growing causes of cancer deaths worldwide.

    01 February 2018 | Eurekalert Medicine & Health
  • Screening for Hepatitis C Improves Opioid Abuse Treatment Outcomes

    Research presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – shows people in treatment for opioid substance abuse significantly lowered their non‐prescribed opioid use after testing positive for hepatitis C virus.

    23 October 2017 | AASLD
  • Hep C: An end in sight?

    Despite its prevalence, hepatitis C has long been under-prioritised by health services. But could new drugs and a new commitment from the NHS mean we may finally see this killer condition eradicated?

    05 October 2017 | Drink & Drug News
  • Targeting MSM with HIV: Treatment as Prevention in the Netherlands

    As part of Dutch HIV guidelines, all individuals with HIV are screened for hepatitis C. Anne Boerekamps, MD, of Erasmus University Medical Center in Rotterdam, the Netherlands, spoke with HCV Next about the Dutch approach, the relevant data, and other topics associated with screening and treating MSM.

    18 July 2017 | Healio Hepatology
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.